# Ryzumvi

NDC: 83368-075
Generic name: phentolamine mesylate
Labeler / Manufacturer: Oyster Point Pharma, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SOLUTION/ DROPS
Routes: OPHTHALMIC
Marketing started: 20240325

FDA application: NDA217064

## Active ingredients

- PHENTOLAMINE MESYLATE: 10 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"83368-075"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=83368-075
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=96bb1e53-c2cc-4e60-a21a-db0269c371bf